Major clinical features of 3 patients with immunodeficiency and immune dysregulation
| . | P1 . | P2 . | P3 . | 
|---|---|---|---|
| Immunodeficiency | |||
| Recurrent respiratory tract infections | ++ | + | ++ | 
| Bronchiectasis | ++ | + | ++ | 
| Herpes viral infection | ++ | + | + | 
| Lymphoproliferation | |||
| Lymphadenopathy | + | + | + | 
| Hepatosplenomegaly | + | + | + | 
| Lymphoma | + | + | + | 
| Autoimmunity | |||
| Autoimmune cytopenias | + | + | − | 
| Autoantibodies | + | + | − | 
| Laboratory values | |||
| Class-switched memory B cells | ↓ | ↓ | ↓ | 
| FasL-mediated apoptosis | ↓ | ↓ | Normal | 
| Soluble FasL | ↑ | ↑ | Normal | 
| DNTs | ↑ | ↑/Normal | ↑ | 
| Specific antibodies | Normal | ND | ↓ | 
| Developmental delay | |||
| Moderate | + | + | + | 
| Outcome of HSCT | |||
| Autologous T-cell reconstitution | + | + | + | 
| Split mixed chimerism | Rejected and died | Rejected and died | 
| . | P1 . | P2 . | P3 . | 
|---|---|---|---|
| Immunodeficiency | |||
| Recurrent respiratory tract infections | ++ | + | ++ | 
| Bronchiectasis | ++ | + | ++ | 
| Herpes viral infection | ++ | + | + | 
| Lymphoproliferation | |||
| Lymphadenopathy | + | + | + | 
| Hepatosplenomegaly | + | + | + | 
| Lymphoma | + | + | + | 
| Autoimmunity | |||
| Autoimmune cytopenias | + | + | − | 
| Autoantibodies | + | + | − | 
| Laboratory values | |||
| Class-switched memory B cells | ↓ | ↓ | ↓ | 
| FasL-mediated apoptosis | ↓ | ↓ | Normal | 
| Soluble FasL | ↑ | ↑ | Normal | 
| DNTs | ↑ | ↑/Normal | ↑ | 
| Specific antibodies | Normal | ND | ↓ | 
| Developmental delay | |||
| Moderate | + | + | + | 
| Outcome of HSCT | |||
| Autologous T-cell reconstitution | + | + | + | 
| Split mixed chimerism | Rejected and died | Rejected and died | 
+, feature present; ++, major feature; −, feature absent; ↓, lower than normal; ↑, higher than normal; ND, not determined.